New award for amoxicillin/clavulanate potassium (K) suspension with sandoz, INC. Ordering period is january 15, 2023, to january 14, 2024, with four one-year options.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79723D0005
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 95% complete
IDV ceiling
$766,987.10
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Sandoz Inc. for amoxicillin/clavulanate potassium suspension on January 15, 2023, with a ceiling value of $766,987.10. No set-aside was used. The ordering period runs from January 15, 2023, through January 14, 2024, followed by four one-year options, with ultimate completion on January 14, 2027. The contract was issued without restrictions on the ordering of products from Sandoz Inc.'s commercial pharmaceutical catalog. Under the VA's prime vendor program, the contract authorizes distribution to VA medical centers, Department of Defense facilities, the Bureau of Prisons, and Indian Health Services locations. The underlying solicitation, posted August 26, 2022, with a due date of September 27, 2022, sought a single source for antibiotic suspension products to support federal healthcare networks. A modification implemented Executive Order 14398 discrimination requirements.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 · Modification to implement EO 14398 DEI discrimination. $0
Add Subcontract Plan P00012 · Incorporate sandoz 2026 subcontracting plan. $0
Exercise an Option P00011 · Exercise option year 3 with no price changes. $0
Other Administrative Action P00010 · Delete NDC for two line items. $0
Supplemental Agreement for work within scope P00009 · Add new NDC for two line items. $0
Add Subcontract Plan P00008 · Incorporate contractor's 2025 small business subcontracting plan into contract. $0
Exercise an Option P00007 · Exercise option year 2 for amoxicillin/clavulanate K suspension with sandoz, INC. Performance period is 1/15/2025 - 1/14/2026. $0
Supplemental Agreement for work within scope P00006 · Update CRF payment submittal and sales reporting $0
Other Administrative Action P00005 · Modification to change POC from evelyn bergman to eric shinn $0
Add Subcontract Plan P00004 · Modification to add 2024 subcontracting plan. EFF. 1/1/2024 - 12/31/2024 $0
Exercise an Option P00003 · Modification to exercise option year 1. Period of performance is 1/15/2024 to 1/14/2025. $0
Other Administrative Action P00002 · Administrative modification to add drug supply chain security act language to contract. $0
Add Subcontract Plan P00001 · Incorporate the 2023 approved small business subcontracting plan. $0
Original award $0
Show all 14

Quick answers

Who was awarded contract 36E79723D0005?

36E79723D0005 was awarded to Sandoz Inc. by National Acquisition Center (Headquarters) on January 15, 2023.

How much is contract 36E79723D0005 worth?

36E79723D0005's own ceiling is $766,987.

Who can order from contract 36E79723D0005?

36E79723D0005 is a single award indefinite delivery contract.

Was contract 36E79723D0005 competed?

The extent of competition for 36E79723D0005 was full and open competition. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV